Abivax (ABVX) plunged in premarket trading on Tuesday despite announcing positive Phase 3 maintenance trial results for its ...

A clinical trial update wiped out billions in the French company's market cap and raised questions over a potential takeover.

Abivax (NASDAQ:ABVX) shares fell sharply on Tuesday after investors focused on reports of rare malignancy cases in a ...

Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but ...

Shares in French biotech Abivax tumbled more than 30% today, after it announced phase 3 data with ulcerative colitis (UC) ...

Jefferies downgraded the French biotech to Hold and cut its price target nearly in half, warning the cancer overhang won't ...

ABIVAX Société Anonyme stock plunged after Phase 3 UC data: efficacy strong but safety flags. Click for this updated look at ...

The company dismissed the cancers observed in the trial as rare, occurring primarily in older patients, and largely unrelated to treatment.

Unfortunately the cause of ulcerative colitis is unknown, although both genetic and the environmental causes have been proposed. Most patients with ulcerative colitis do not have anyone else in the ...

Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD). It causes painful sores and inflammation deep inside your colon and rectum. That can lead to hard-to-manage symptoms like ...

While some studies suggest CBD oil may help reduce inflammation and provide symptomatic relief for ulcerative colitis, more research is needed to confirm its effectiveness. The FDA has not approved ...